Eramo A - Search Results

1

Lung Cancer Organoids: The Rough Path to Personalized Medicine.

Rossi R, De Angelis ML, Xhelili E, Sette G, Eramo A, De Maria R, Cesta Incani U, Francescangeli F, Zeuner A. Rossi R, et al. Among authors: eramo a. Cancers (Basel). 2022 Jul 29;14(15):3703. doi: 10.3390/cancers14153703. Cancers (Basel). 2022. PMID: 35954367 Free PMC article. Review.

2

Caspase activation without death.

Zeuner A, Eramo A, Peschle C, De Maria R. Zeuner A, et al. Among authors: eramo a. Cell Death Differ. 1999 Nov;6(11):1075-80. doi: 10.1038/sj.cdd.4400596. Cell Death Differ. 1999. PMID: 10578176 Review.

3

Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.

Zeuner A, Eramo A, Testa U, Felli N, Pelosi E, Mariani G, Srinivasula SM, Alnemri ES, Condorelli G, Peschle C, De Maria R. Zeuner A, et al. Among authors: eramo a. Cell Death Differ. 2003 Aug;10(8):905-13. doi: 10.1038/sj.cdd.4401255. Cell Death Differ. 2003. PMID: 12867998

4

CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells.

Eramo A, Sargiacomo M, Ricci-Vitiani L, Todaro M, Stassi G, Messina CG, Parolini I, Lotti F, Sette G, Peschle C, De Maria R. Eramo A, et al. Eur J Immunol. 2004 Jul;34(7):1930-40. doi: 10.1002/eji.200324786. Eur J Immunol. 2004. PMID: 15214041 Free article.

5

Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.

Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, Crinò L, Peschle C, De Maria R. Eramo A, et al. Cancer Res. 2005 Dec 15;65(24):11469-77. doi: 10.1158/0008-5472.CAN-05-1724. Cancer Res. 2005. PMID: 16357155

6

Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.

Conticello C, Adamo L, Giuffrida R, Vicari L, Zeuner A, Eramo A, Anastasi G, Memeo L, Giuffrida D, Iannolo G, Gulisano M, De Maria R. Conticello C, et al. Among authors: eramo a. J Clin Endocrinol Metab. 2007 May;92(5):1938-42. doi: 10.1210/jc.2006-2157. Epub 2007 Feb 27. J Clin Endocrinol Metab. 2007. PMID: 17327374

7

Identification and expansion of the tumorigenic lung cancer stem cell population.

Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. Eramo A, et al. Cell Death Differ. 2008 Mar;15(3):504-14. doi: 10.1038/sj.cdd.4402283. Epub 2007 Nov 30. Cell Death Differ. 2008. PMID: 18049477

8

Lung cancer stem cells: tools and targets to fight lung cancer.

Eramo A, Haas TL, De Maria R. Eramo A, et al. Oncogene. 2010 Aug 19;29(33):4625-35. doi: 10.1038/onc.2010.207. Epub 2010 Jun 7. Oncogene. 2010. PMID: 20531299 Review.

9

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.

Tafani M, Di Vito M, Frati A, Pellegrini L, De Santis E, Sette G, Eramo A, Sale P, Mari E, Santoro A, Raco A, Salvati M, De Maria R, Russo MA. Tafani M, et al. Among authors: eramo a. J Neuroinflammation. 2011 Apr 13;8:32. doi: 10.1186/1742-2094-8-32. J Neuroinflammation. 2011. PMID: 21489226 Free PMC article.

10

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

Bartucci M, Svensson S, Romania P, Dattilo R, Patrizii M, Signore M, Navarra S, Lotti F, Biffoni M, Pilozzi E, Duranti E, Martinelli S, Rinaldo C, Zeuner A, Maugeri-Saccà M, Eramo A, De Maria R. Bartucci M, et al. Among authors: eramo a. Cell Death Differ. 2012 May;19(5):768-78. doi: 10.1038/cdd.2011.170. Epub 2011 Nov 25. Cell Death Differ. 2012. PMID: 22117197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page